Knowledge Center
Article / Feb 01, 2015
The Time Has Come
Source:
PMPS, 2015, February, pp. 30 - 33
The respiratory drug sector is experiencing a surge of interest as companies seek to capitalise on the rapidly growing market.
With new product launches and novel formulation combinations in development, inhaled drug delivery is reaching far beyond its origins in asthma and COPD treatments.
Related links
Also in the Knowledge Center
/ Sep 01, 2023
In vitro dissolution/permeation tools for amorphous solid dispersions bioavailability forecasting I: Experimental design for PermeaLoop
Read more
Scientific Article
/ Sep 01, 2023
In vitro dissolution/permeation tools for amorphous solid dispersions bioavailability forecasting II: Comparison and mechanistic insights
Read more
Scientific Article
/ Aug 25, 2023
Nasal-PAMPA: A novel non-cell-based high throughput screening assay for prediction of nasal drug permeability
Read more
Scientific Article